NCT06514794
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06514794
Title A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wugen, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Children's Hospital Los Angeles RECRUITING Los Angeles California 90027 United States Details
Washington University Saint Louis RECRUITING St Louis Missouri 63108 United States Details
Children's Hospital of Philadelphia RECRUITING Philadelphia Pennsylvania 19390 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Peter Mac Callum Cancer Institute RECRUITING Melbourne Victoria 3000 Australia Details
Royal Children's Melbourne RECRUITING Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field